Positron emission tomography with fluorine-18 fluorodeoxyglucose to evaluate response of early breast carcinoma treated with stereotaxic interstitial laser therapy

Clinical Nuclear Medicine

Volumn 25, Issue 7, 2000, Pages 505-507

  Nair, Narendra ^a   Ali, Amjad ^a   Dowlatshahi, Kambiz ^a   Fan, Ming ^a   Lamonica, Greg ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast Cancer; Fluorodeoxyglucose uptake; Laser; Positron Emission Tomography; Stereotaxis; Thermal Coagulation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BREAST CARCINOMA; CASE REPORT; FEMALE; HUMAN; LASER SURGERY; POSITRON EMISSION TOMOGRAPHY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LASER COAGULATION; MIDDLE AGED; RADIOPHARMACEUTICALS; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034086493     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200007000-00001     Document Type: Article

References (21)

1. Dowlatshahi K, Fan M, Shekarloo M, Bloom KJ, Gould VE: Stereotaxic interstitial laser therapy of early-stage breast cancer. The Breast Journal 2:304, 1996.
2. Hamid Mumtaz, Hasll-Croggs MA, Wetherspoon A, et al: Laser therapy for breast cancer, MRI imaging and histopathologic correlation. Radiology 200:651, 1996.
3. Akimov AB, Seregin AE, Rusanov KV, et al: Interstitial laser thermotherapy in the treatment of breast cancer. Laser Surg Med 22:257, 1998.
4. Foster GS, Dowlatshahi K, Fan M: Contrast-enhanced power Doppler US imaging in evaluation of tumor coagulation by interstitial lase therapy. Proceedings of 95th Annual Meeting of American Roentgen Ray Society. Washington, DC, April 30-May 5, 1995, p 78.
5. Harries SA, Amin Z, Smith MEF, et al: Interstitial laser photocoagulation as a treatment for breast cancer. Br J Surg 81:1617, 1994.
6. Wagner HN Jr: Clinical PET: Its time has come. J Nucl Med 32:561, 1991.
7. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL: Evaluation of breast masses and axillary lymph nodes with (F-18)2-deoxy-2-fluoro-D-glucose PET. Radiology 187:743, 1996.
8. Avril N, Janicke F, Dose J, et al: Imaging of breast tumors with FDG PET in comparison with histology. Eur J Nucl Med 21: 749, 1994.
9. Chaiken L, Rege S, Hoh C, et al: Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 27: 455, 1993.
10. Yonekura Y, Benua RS, Brill AB, et al: Increased accumulation of 2-deoxy-2-[F-18]Fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 23:1133, 1982.
11. Bury T, Dowlati A, Paulus P, et al: Staging of non small lung cancer by whole body 18FDG PET. Eur J Nucl Med 23:204, 1996.
12. Inoue T, Kim EE, Komaki R, et al: Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 36:788, 1995.
13. Beets G, Penninckx F, Schiepers C, et al: Clinical value of whole-body positron emission tomography with 18-F-fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81:1666, 1994.
14. Gupta N, Bradfield H: Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 26:65, 1996.
15. Kern KA, Brunetti A, Norton JA, et al: Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 29:181, 1988.
16. Adler LP. Blair HF, Makley JT, et al: Non invasive grading of musculoskeletal tumors using PET. J Nucl Med 32:1508, 1991.
17. Abella E, DiCarli M, Ravindranath Y, et al: Positron emission tomography (PET) scanning with 18-fluorodeoxyglucose (FDG) correlates with histological response in children with osteosarcoma (OS) and Ewing's sarcoma (ES) [Meeting Abstract]. Proceedings of the Annual Meeting of the American Society of Clinical Oncololgy 15:A1457, 1996.
18. Powe JE: Positron emission tomography (PET) scanning in breast cancer. Br J Radiol 70:668, 1997.
19. Wahl RL, Zasadny K, Helvie M, et al: Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation. J Clin Oncol 11:2101, 1993.
20. Glaspy JA, Hawkins R, Hoh CK, Phelps ME: Use of positron emission tomography in oncology. Oncology 7:41 [discussion on 50, 55], 1993.
21. Wahl RL, Cody RL, Hutchins GD, Mudgett EE: Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179:765, 1991.